Philips sleep disorder threatens a rising invoice

Philips CEO Frans van Houten presents financial in Amsterdam, the Netherlands, January 29, 2019. REUTERS / Eva Plevier

Register now for FREE unlimited access to

to register

, Nov. 15 (Reuters Breakingviews) – A night’s sleep is a luxury that Koninklijke Philips (PHG.AS) investors may not have for some time. The Dutch electronics giant’s shares fell 11% Monday morning after Chief Executive Frans van Houten said the U.S. Food and Drug Administration (FDA) asked them to conduct new tests on foams used in 4 million recalled respirators. The regulator also said the company’s new design may be inadequate.

The ventilators are designed to help restless sleepers. But the polyester-based polyurethane foam that keeps them quiet can cause the user to inhale toxic and potentially carcinogenic chemicals. Philips has already provided 500 million to repair the recalled devices. In addition, due to the discontinuation of new production, around 700 million in annual sales will be lost. If the company doesn’t meet the FDA, it could be forced to spend more and stop manufacturing longer. The $ 4 billion decline in the company’s market value suggests investors are also concerned about litigation. The Philips nightmare may only be beginning. (by Aimee Donnellan)

On Twitter

Register now for FREE unlimited access to

to register

Capital Calls – Deeper Insights into Global Finance:

IPO detour in Hong Kong will be rockier read on

Lordstown has problems switching Read more

CVC finds bargains in land grabbing through fund management read on

Alibaba can’t contain the surplus at the shopping festival Read more

Tesla Money Train enriches more than just CEO read on

Register now for FREE unlimited access to

to register

Editing by Peter Thal Larsen and Oliver Taslic

Reuters Breakingviews is the world’s leading source for agenda setting financial information. As a Reuters financial commentary brand, we analyze the great business and economic stories that go around the world every day. A global team of around 30 correspondents in New York, London, Hong Kong and other major cities provide expert analysis in real time.

Sign up for a free trial of our full service at and follow us on Twitter @Breakingviews and at All opinions expressed are those of the authors.

Leave a comment

Your email address will not be published. Required fields are marked *